REVB Logo

Revelation Biosciences, Inc. (REVB) 

NASDAQ
Market Cap
$2.96M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
856 of 958
Rank in Industry
480 of 549

Largest Insider Buys in Sector

REVB Stock Price History Chart

REVB Stock Performance

About Revelation Biosciences, Inc.

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a …

Insider Activity of Revelation Biosciences, Inc.

Over the last 12 months, insiders at Revelation Biosciences, Inc. have bought $0 and sold $0 worth of Revelation Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Revelation Biosciences, Inc. have bought $151,908 and sold $2.26M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $29,000 was made by TIDMARSH GEORGE F (director) on 2023‑04‑18.

List of Insider Buy and Sell Transactions, Revelation Biosciences, Inc.

2023-12-08Saledirector
27,771
0.4059%
$0.52$14,438-88.48%
2023-10-16Saledirector
12,802
0.1963%
$0.66$8,442-88.31%
2023-09-28Saledirector
1,429
0.0232%
$0.69$986-88.01%
2023-09-18Saledirector
4,000
0.0648%
$0.74$2,960-88.05%
2023-09-15Saledirector
9,500
0.1449%
$0.73$6,935-88.60%
2023-09-14Saledirector
12,000
0.1906%
$0.75$9,000-88.44%
2023-04-18Purchasedirector
25,000
1.1925%
$1.16$29,000-38.61%
2023-04-17Purchasedirector
26,500
1.1885%
$1.16$30,740-42.24%
2022-02-25Purchase
20,000
0.1609%
$1.60$32,000-70.02%
2022-02-09Purchase
30,000
0.2157%
$2.55$76,599-81.48%
2022-02-08Purchase
1,000
0.007%
$2.54$2,540-81.68%
2022-02-07Purchase
42,100
0.2939%
$2.61$109,780-82.13%
2022-02-04Purchase
9,900
0.0679%
$2.34$23,156-80.31%
2021-09-23Sale10 percent owner
611,541
4.7291%
$10.08$6.16M-87.29%
2021-09-22Sale10 percent owner
5
<0.0001%
$10.08$50-87.29%
2021-09-21Sale10 percent owner
43,000
0.3323%
$10.08$433,440-87.20%
2020-11-09Sale10 percent owner
5,000
0.0396%
$10.00$50,000+1388373.68%
2020-10-12Sale10 percent owner
20
0.0002%
$10.00$200+1386811.84%
2020-10-09Sale10 percent owner
9,328
0.0738%
$10.00$93,280+1386314.47%

Insider Historical Profitability

<0.0001%
TIDMARSH GEORGE Fdirector
0
0%
$0.3576<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.